Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.

President-elect Trump has nominated biotech investor Jim O’Neill for deputy secretary of the Health and Human Services ...

Bhattacharya would be in charge of Trump's bold goals to reform the NIH, which spends billions to fund medical research.

Opinion: Low pay, high pressure, a troubling political landscape — it’s all leading to medical students electing not to ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

I spent four crazy years writing about Cassava Sciences, Adam Feuerstein writes. Yesterday, the story ended exactly as many ...

The law is intended to crack down on Chinese biotech companies, but it may become more difficult to pass next year.

Health officials in British Columbia, Canada, have failed, for now, to confirm how a teenager there became infected with H5N1 ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

Marty Makary, a Johns Hopkins surgeon and outspoken critic of parts of the U.S. medical system, is Trump’s pick for FDA ...

The Office for Civil Rights is not checking if health care providers who handle Americans’ sensitive data comply with health ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.